Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells

Hypertension Research

Volumn 21, Issue 2, 1998, Pages 109-119

  Kashiwagi, Yusuke ^a   Haneda, Takashi ^a   Osaki, Junzo ^a   Miyata, Setsuya ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Cardiac hypertrophy; HMG CoA reductase inhibitor; Lovastatin; Mitogen activated protein kinase; Ras protein

Indexed keywords

CALPHOSTIN C; DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; MEVALONIC ACID; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE C; RAS PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MUSCLE STRETCHING; NEWBORN; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; PROTEIN CONTENT; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS;

EID: 0031903702     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.21.109     Document Type: Article

References (41)

1. Morgan HE, Baker KM: Cardiac hypertrophy, mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13-25.
2. Komuro I, Kaida T, Shibazaki Y, et al: Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem 1990; 265: 3595-3598.
3. Sadoshima J, Izumo S: Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: Potential involvement of an autocrine/paracrine mechanism. EMBO J 1993; 12: 1681-1692.
4. Miyata S, Haneda T, Osaki J, Kikuchi K: Reninangiotensin system in stretch-induced hypertrophy of cultured neonatal rat heart cells. Eur J Pharmacol 1996; 307: 81-88.
5. Yamazaki T, Tobe K, Hoh E, et al: Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 1993; 268: 12069-12076.
6. Yamazaki T, Komuro I, Kudoh S, et al: Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J Clin Invest 1995; 96: 438-446.
7. Crews CM, Erikson RL: Extracellular signals and reversible protein phosphorylation: what to mek of it all. Cell 1993; 74: 215-217.
8. Gibbs JB: Ras C-terminal processing enzymes - new drug targets? Cell 1991; 65: 1-4.
9. Maltese WA: Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J 1990; 4: 3319-3328.
10. Hancock JF, Magee AI, Childs JE, Mashall CJ: All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989; 57: 1167-1177.
11. Maltese WA, Defendini R, Green RA, Sheridan KM, Donley DK: Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Clin Invest 1985; 76: 1748-1754.
12. Schafer WR, Kim R, Sterne R, Thorner J, Kim SH, Rine J: Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science 1989; 245: 379-385.
13. Thorburn A, Thorburn J, Chen SY, et al: HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 1993; 268: 2244-2249.
14. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996; 15: 775-787.
15. Haneda T, McDermott PJ: Stimulation of ribosomal RNA synthesis during hypertrophic growth of cultured heart cells by phorbol ester. Mol Cell Biochem 1991; 104: 169-177.
16. Miyata S, Haneda T: Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol 1994; 266 (Heart Circ Physiol, 35): H2443-H2451.
17. Kobayashi E, Nakano H, Morimoto M, Tamaoki J: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1984; 121: 649-656.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Cesarone CF, Bolognesi C, Santi L: Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 1979; 100: 188-197.
20. Munro HN: The determination of nucleic acids. Methods of Biochemical Analysis 1966; 14: 113-176.
21. McKee EE, Cheung JY, Rannels DE, Morgan HE: Measurement of the rate of protein synthesis and compartmentation of the heart phenylalanine. J Biol Chem 1978; 253: 1030-1040.
22. Morgan HE, Earl DC, Broadus A, Wolpert EB, Giger KE, Jefferson LS: Regulation of protein synthesis in heart muscle. I. Effect of amino acid levels on protein synthesis. J Biol Chem 1971; 246: 2152-2162.
23. Allo SN, McDermott PJ, Carl LL, Morgan HE: Phorbol ester stimulation of protein kinase C activity and ribosomal DNA transcription. J Biol Chem 1991; 266: 22003-22009.
24. Sirakabe K, Gotoh Y, Nishida E: A mitogen-activated protein (MAP) kinase activating factor in mammalian mitogen-stimulated cells is homologous to Xenopus M phase MAP kinase activator. J Biol Chem 1992; 267: 16685-16690.
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
26. Bogoyevitch MA, Sugden PH: The role of protein kinases in adaptational growth of the heart. Int J Biochem Cell Biol 1996; 28: 1-12.
27. Crews CM, Alessandrini A, Erikson RL: The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992; 258: 478-484.
28. Kyriakis JM, App H, Zhang XF, et al: Raf-1 activates MAP kinase-kinase. Nature 1992; 358: 417-421.
29. Duff JL, Berk BC, Corson MA: Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinase in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1992; 118: 257-264.
30. Blenis J: Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 1993; 90: 5589-5892.
31. Daum G, Tappe IE, Fries HW, Troppmair J, Rapp UR: The ins and outs of Raf kinases. Trends Biochem Sci 1994; 19: 474-479.
32. Avruch J, Zhang X, Kyriakis J: Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 1994; 19: 279-283.
33. Rodriguez VP, Warne PH, Dhand R, et al: Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994; 370: 527-532.
34. Satoh T, Nakafuku M, Kaziro Y: Function of ras as a molecular switch in signal transduction. J Biol Chem 1992; 267: 24149-24152.
35. Zou Y, Yamazaki T, Aikawa R, Kudoh S, Komuro I: Protein kinase C, but not Src or Ras, plays a critical role in angiotensin II-induced Raf-1 kinase/ extracellular signal-regulated protein kinase activation in cardiac myocytes. Circulation 1996; 94 (Suppl): 2358 (Abstract).
36. Willumsen BM, Norris K, Papageorge AG, Hubbert NL, Lowy DR: Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J 1984; 3: 2581-2585.
37. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990; 343: 425-430.
38. Repko EM, Maltese WA: Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J Biol Chem 1989; 264: 9945-9952.
39. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 1993; 91: 83-87.
40. Nakase T, Kawata S, Tamura S, et al: Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor. A preferential suppression of ras farnesylation. Int J Cancer 1996; 65: 620-626.
41. Serajuddin ATM, Ranadive SA, Mahoney EM: Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simbastatin. J Pharm Sci 1991; 80: 830-834.